Brella Publications & Presentations

Candesant is focused on developing and commercializing non-invasive treatments for hyperhidrosis (excessive sweating) that are safe, effective, quick, comfortable, and easy for practices to integrate.

Recently, Candesant data was accepted for publication in prominent, peer-reviewed medical journals and presented at medical meetings, including:

A Pilot Study of the Safety and Effectiveness of a Novel Device in Subjects With Axillary Hyperhidrosis

Dermatologic Surgery

November 2022

Outcomes from the SAHARA Clinical Study on the TAT Patch for Excessive Axillary Sweating or Primary Axillary Hyperhidrosis (abstract)

American Academy of Dermatology annual meeting; March 17-21 (presented March 18, 10:10 am CT), 2023; New Orleans, Louisiana.

March 2023

Quality of Life Improvement shown during SAHARA Clinical Study on the TAT Patch for Excessive Axillary Sweating or Primary Axillary Hyperhidrosis

Cosmetic Boot Camp (CBC) conference, June 22-25,
2023, Aspen, Colorado.

June 2023

Primary Axillary Hyperhidrosis or Excessive Axillary Sweating in Aesthetics Patients: Prevalent, Mostly Undiagnosed, Embarrassing, Impairs Quality of Life, Demonstrates Need for New Treatment.

Electronic poster presentation at: Cosmetic Boot Camp; June 22-25, 2023; Aspen, Colorado.

June 2023

Cheerful Blonde Woman Pointing to the form

Sign up to learn more and to reserve your spot to add Brella^® to your practice

Cart

Your cart is empty

Brella Publications & Presentations

Sign up to learn more and to reserve your spot to add Brella® to your practice

Cart

Brella Publications & Presentations

Sign up to learn more and to reserve your spot to add Brella® to your practice

Sign up to learn more and to reserve your spot to add Brella^® to your practice

Sign up to learn more and to reserve your spot to add Brella^® to your practice